Tianjin Pharmaceutical Da Ren Tang's (SGX:T14) unit, Xinxin Pharmaceutical Plant, was issued a drug registration certificate by the National Medical Products Administration of China, according to a Tuesday filing with the Singapore Exchange.

The certificate is for the distribution of Loxoprofen Sodium Cataplasms, which is manufactured by Beijing Baiao Pharmaceutical.

Shares of the company were up over 1% at the close of trade on Tuesday.